SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-22-022760
Filing Date
2022-02-14
Accepted
2022-02-14 16:11:55
Documents
1
Group Members
PETER KOLCHINSKYRA CAPITAL HEALTHCARE FUND, L.P.RAJEEV SHAH

Document Format Files

Seq Description Document Type Size
1 CHEMOCENTRYX, INC. tm225316d2_sc13ga.htm SC 13G/A 88628
  Complete submission text file 0001104659-22-022760.txt   90336
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Subject) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86723 | Film No.: 22631944
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, L.P. (Filed by) CIK: 0001346824 (see all company filings)

IRS No.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A